Chaodong Wu Selected Research

Chaodong Wu Research Topics

Disease

30	Inflammation (Inflammations) 01/2022 - 07/2009
23	Insulin Resistance 01/2021 - 01/2002
15	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2012
14	Obesity 01/2022 - 01/2012
13	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 12/2017
9	Fibrosis (Cirrhosis) 01/2022 - 11/2004
8	Hyperglycemia 01/2019 - 01/2002
7	Body Weight (Weight, Body) 03/2022 - 08/2005
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2002
4	Sclerosing Cholangitis 03/2022 - 10/2019
4	Atherosclerosis 01/2020 - 07/2009
3	Cholestasis 01/2021 - 01/2019
3	Metabolic Diseases (Metabolic Disease) 01/2021 - 06/2015
3	Bites and Stings (Sting) 01/2020 - 01/2017
3	Hypoxia (Hypoxemia) 01/2019 - 01/2017
3	Glucose Intolerance 12/2018 - 07/2010
3	Wounds and Injuries (Trauma) 01/2018 - 02/2013
2	Weight Loss (Weight Reduction) 01/2022 - 09/2019
2	Neoplasms (Cancer) 10/2021 - 04/2016
2	Fatty Liver 10/2021 - 12/2017
2	Hypertrophy 01/2021 - 11/2004
2	Heart Failure 01/2021 - 01/2021
2	Hyperplasia 01/2020 - 01/2019
2	Liver Diseases (Liver Disease) 01/2018 - 06/2015
2	Overnutrition 05/2013 - 04/2013
2	Neointima 02/2013 - 05/2010
1	Cognitive Dysfunction 03/2022
1	Alcoholic Fatty Liver 01/2022
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Carcinoma (Carcinomatosis) 10/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2021
1	Cholangiocarcinoma 04/2021
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2021

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2002
9	Phosphotransferases (Kinase)IBA 01/2021 - 11/2004
9	Insulin (Novolin)FDA Link 01/2021 - 01/2002
8	CytokinesIBA 01/2021 - 07/2009
7	FructoseIBA 01/2021 - 11/2004
7	Messenger RNA (mRNA)IBA 01/2021 - 01/2012
7	Adenosine (Adenocard)FDA LinkGeneric 09/2019 - 01/2017
5	Phosphofructokinase-2 (Phosphofructokinase 2)IBA 01/2021 - 02/2010
5	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2017
5	EnzymesIBA 01/2017 - 01/2002
4	Choline (Choline Chloride)IBA 01/2022 - 09/2019
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2017
4	Rosiglitazone (Avandia)FDA Link 01/2021 - 07/2010
4	oxidized low density lipoproteinIBA 01/2020 - 01/2016
4	Metformin (Glucophage)FDA LinkGeneric 07/2017 - 01/2014
3	Methionine (L-Methionine)FDA Link 01/2022 - 09/2019
3	LipidsIBA 10/2021 - 12/2012
3	secretin receptorIBA 10/2021 - 10/2018
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2014
3	3- tert- butoxycarbonylmethyl- 5- (4- (2- (N- methyl- N- (2- pyridyl)amino)ethoxy)benzyl)thiazolidine- 2,4- dioneIBA 01/2021 - 01/2014
3	MorpholinosIBA 11/2020 - 12/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2020 - 01/2017
3	NF-kappa B (NF-kB)IBA 09/2019 - 01/2016
3	CholesterolIBA 07/2019 - 07/2009
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019 - 07/2009
3	Adenosine KinaseIBA 01/2019 - 10/2017
3	ApolipoproteinsIBA 12/2018 - 07/2009
3	Apolipoproteins E (ApoE)IBA 12/2018 - 07/2009
2	Bile Acids and Salts (Bile Acids)IBA 03/2022 - 01/2017
2	indoleIBA 01/2022 - 10/2020
2	Secretin FDA Link 10/2021 - 10/2018
2	ThiazolidinedionesIBA 01/2021 - 09/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 05/2013
2	Small Interfering RNA (siRNA)IBA 11/2020 - 01/2016
2	Sirtuin 1IBA 11/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 09/2019
2	EndotoxinsIBA 01/2020 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019 - 12/2018
2	JNK Mitogen-Activated Protein KinasesIBA 09/2019 - 12/2018
2	LDL Receptors (LDL Receptor)IBA 07/2019 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2012
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 07/2017
2	LipopolysaccharidesIBA 12/2018 - 05/2010
2	Interferon Type IIBA 12/2018 - 01/2017
2	vadimezanIBA 12/2018 - 01/2017
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2018 - 01/2017
2	bisphenol AIBA 01/2018 - 01/2017
2	Retinaldehyde (Retinal)IBA 01/2017 - 01/2017
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017 - 05/2010
2	Fish OilsIBA 01/2017 - 01/2012
2	AMP-Activated Protein KinasesIBA 03/2016 - 12/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2022
1	AZD4547IBA 01/2022
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2022
1	Volatile Fatty AcidsIBA 11/2021
1	Dietary Fiber FDA Link 11/2021
1	Plant ExtractsIBA 10/2021
1	fascinIBA 10/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 10/2021
1	4- oxo- 6- ((pyrimidin- 2- ylthio)methyl)- 4H- pyran- 3- yl 4-nitrobenzoateIBA 01/2021
1	Atrial Natriuretic Factor (ANF)IBA 01/2021

Therapy/Procedure

4	Therapeutics 04/2021 - 01/2002
2	Transplantation 12/2018 - 06/2012
1	Aftercare (After-Treatment) 01/2021